Patents by Inventor Takenori INOMATA

Takenori INOMATA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD AND SYSTEM FOR EVALUATING RISK OF AGE-RELATED MACULAR DEGENERATION
    Publication number: 20210116466
    Abstract: An AMD risk evaluation method is provided. The concentrations of a set of evaluation elements contained in a serum sample 2 taken from a subject are measured (step S1), the concentration data of the set of evaluation elements thus measured are applied to a predetermined discriminant function to perform an operation (step S2); and whether or not the subject suffers from AMD is discriminated based on the operation result obtained by applying the concentration data to the discriminant function (step S3). The discrimination is carried out in accordance with the concentration balance (pattern) of the set of evaluation elements. The set of evaluation elements is designated by choosing all or part of specific elements that have the concentration data for both of the case group and the control group based on the discriminant abilities in arbitrary combinations of the specific elements.
    Type: Application
    Filed: April 4, 2018
    Publication date: April 22, 2021
    Applicants: Renatech Co., Ltd., Juntendo Educational Foundation
    Inventors: Seiichi Inagaki, Naoyuki Okamoto, Takenori Inomata
  • Rejection reaction suppressant
    Patent number: 10537579
    Abstract: To provide a novel method for suppressing rejection after corneal transplantation. The method for suppressing rejection after corneal transplantation includes administering an effective amount of a Rho kinase inhibitor to a patient who needs it.
    Type: Grant
    Filed: May 10, 2018
    Date of Patent: January 21, 2020
    Assignees: JUNTENDO EDUCATIONAL FOUNDATION, KOWA COMPANY, LTD.
    Inventors: Takenori Inomata, Toshinari Funaki
  • REJECTION REACTION SUPPRESSANT
    Publication number: 20180325913
    Abstract: To provide a novel method for suppressing rejection after corneal transplantation. The method for suppressing rejection after corneal transplantation includes administering an effective amount of a Rho kinase inhibitor to a patient who needs it.
    Type: Application
    Filed: May 10, 2018
    Publication date: November 15, 2018
    Applicants: JUNTENDO EDUCATIONAL FOUNDATION, KOWA COMPANY, LTD.
    Inventors: Takenori INOMATA, Toshinari Funaki